Why choose us?
Proven track record in providing innovative and cost effective support in all aspects of regulatory work to our partners...
Our core services
Project Management and support to the generic and non-generic pharmaceutical industry.
- FDA issues final guidance on the evaluation and labeling of abuse-deterrent opioids April 1, 2015
- FDA expands use of CoreValve System for aortic “valve-in-valve” replacement March 30, 2015
- California seafood company to cease production of adulterated fish March 30, 2015
- FDA approves new treatment for diabetic retinopathy in patients with diabetic macular edema March 25, 2015
- FDA approves treatment for inhalation anthrax March 25, 2015
- FDA approves blood pump system to help patients maintain stable heart function during certain high-risk cardiac procedures March 23, 2015
- FDA concludes Arctic Apples and Innate Potatoes are safe for consumption March 20, 2015
- FDA approves Cholbam to treat rare bile acid synthesis disorders March 17, 2015
- FDA releases final guidance on reprocessing of reusable medical devices March 12, 2015
- Federal judge enters consent decree against Specialty Compounding LLC March 11, 2015
- FDA approves first therapy for high-risk neuroblastoma March 10, 2015
- FDA approves CPR devices that may increase chance of surviving cardiac arrest March 9, 2015
- FDA approves new antifungal drug Cresemba March 6, 2015
- FDA authorizes use of first device to treat patients with dialysis-related amyloidosis March 6, 2015
- FDA approves first biosimilar product Zarxio March 6, 2015
For more information regarding Press and Publications please contact: JSK RegLink through email firstname.lastname@example.org or over the telephone +44 (0)20 857 43684
- 2010/11/01: Successful launch of our new website
To view PDF files you will require Adobe Reader